Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 7/20 | 0.75 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.52 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6081481 | 0.80 | GHSR (0.76) | GHSRNPSR1GAAL3MBTL1LMNA | |
| SCHEMBL3639749 | 0.72 | GHSR (0.72) | GHSRKMT2A | |
| SCHEMBL14427571 | 0.72 | TSHR (1.00) | NPSR1CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6080755 | 0.72 | GHSR (0.65) | GHSRGAALMNATSHRPTGS2 | |
| SCHEMBL11375807 | 0.71 | HPGD (1.00) | CYP3A4CYP2C9CYP2C19GAALMNA | |
| SCHEMBL3636000 | 0.71 | GHSR (0.78) | GHSRCYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL12204566 | 0.70 | TSHR (0.89) | GHSRNPSR1L3MBTL1LMNATSHR | |
| SCHEMBL701923 | 0.70 | TAS1R3 (1.00) | GAALMNAALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL3631940 | 0.69 | GHSR (1.00) | GHSRNPSR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18046667 | 0.69 | PTGS2 (0.61) | GHSRNPSR1CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060089398-A1 | Isoxazole carboxamide derivatives as ghrelin receptor modulators | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-04-27 | — | — | US | claimed |
| US-20100093638-A1 | TREAMENT FOR CHEMICAL SUBSTANCE ADDICTION | ABUNON AB (SE) | 2010-04-15 | — | — | US | disclosed |
| EP-2155227-A1 | NEW TREATMENT FOR CHEMICAL SUBSTANCE ADDICTION | Dickson, Suzanne L (SE) | 2010-02-24 | — | — | EP | disclosed |
| WO-2009020419-A1 | NEW TREATMENT FOR CHEMICAL SUBSTANCE ADDICTION | DICKSON SUZANNE L (SE) | 2009-02-12 | — | — | WO | disclosed |
| US-20060089398-A1 | Isoxazole carboxamide derivatives as ghrelin receptor modulators | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089398-A1 | Isoxazole carboxamide derivatives as ghrelin receptor modulators | GPR119, GIPR, GLP1R | GHSR 5/4885NPSR1 722/4885CYP3A4 3261/4885 |
| US-20100093638-A1 | TREAMENT FOR CHEMICAL SUBSTANCE ADDICTION | GHSR, GHRHR, TRHR | GHSR 1/4885NPSR1 34/4885CYP3A4 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.